| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 160.722 | 22.511 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 160.722 | 22.899 | 0 | 0 | 11.301 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 171.444 | 82.560 | 5.342 | 15.236 | 6.407 | 1.930 | 1.559 | 1.017 | 933 | 410 |
| Gross Profit/Loss - EUR | -10.722 | -59.661 | -5.342 | -15.236 | 4.894 | -1.930 | -1.559 | -1.017 | -933 | -410 |
| Net Profit/Loss - EUR | -11.679 | -59.661 | -5.342 | -15.236 | 4.555 | -1.930 | -1.559 | -1.017 | -933 | -410 |
| Employees | 3 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Romanian Clinical Research Trials Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 103.061 | 11.695 | 9.204 | 6.318 | 5.297 | 3.438 | 1.961 | 1.082 | 300 | 0 |
| Current Assets | 51.575 | 3.015 | 3.002 | 3.069 | 1.722 | 2.011 | 54 | 56 | 54 | 53 |
| Inventories | 6.557 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 36.176 | 2.891 | 2.987 | 3.052 | 1.700 | 2.000 | 51 | 51 | 51 | 50 |
| Cash | 8.842 | 123 | 15 | 17 | 21 | 10 | 3 | 5 | 3 | 3 |
| Shareholders Funds | 63.427 | 3.091 | -2.320 | -8.195 | -3.723 | -5.582 | -7.088 | -8.127 | -9.035 | -9.394 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 91.254 | 11.619 | 14.526 | 17.582 | 11.080 | 11.031 | 9.102 | 9.265 | 9.388 | 9.448 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7211 - 7211" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Romanian Clinical Research Trials Srl